TransMedics Group, Inc.
TMDX
$125.17
-$3.33-2.59%
NASDAQ
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | 9.64% | 18.02% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 9.64% | 18.02% | |||
Cost of Revenue | 9.89% | 11.49% | |||
Gross Profit | 9.48% | 22.52% | |||
SG&A Expenses | 1.06% | -6.99% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 4.06% | 2.76% | |||
Operating Income | 33.25% | 217.48% | |||
Income Before Tax | 35.64% | 281.69% | |||
Income Tax Expenses | 28.27% | 653.03% | |||
Earnings from Continuing Operations | 35.92% | 274.54% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 35.92% | 274.54% | |||
EBIT | 33.25% | 217.48% | |||
EBITDA | 28.94% | 134.43% | |||
EPS Basic | 35.15% | 273.15% | |||
Normalized Basic EPS | 34.87% | 280.31% | |||
EPS Diluted | 30.83% | 251.10% | |||
Normalized Diluted EPS | 33.49% | 236.58% | |||
Average Basic Shares Outstanding | 0.57% | 0.38% | |||
Average Diluted Shares Outstanding | 1.61% | 13.36% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |